How Do Physicians Adopt and Apply Opioid Prescription Guidelines in the Emergency Department? A Qualitative Study - 21/10/14


Abstract |
Study objective |
An increase in prescriptions for opioid pain medications has coincided with increasing opioid overdose deaths. Guidelines designed to optimize opioid prescriptions written in the emergency department have been implemented, with substantial controversy. Little is known about how physicians perceive and apply these guidelines. We seek to identify key themes about emergency physicians' definition, awareness, use, and opinions of opioid-prescribing guidelines.
Methods |
We conducted semistructured qualitative interviews with a convenience sample of 61 emergency physicians attending the American College of Emergency Physicians Scientific Assembly (October 2012, Denver, CO). Participants varied with respect to age, sex, geographic region, practice setting, and years of practice experience. We analyzed the interview content with modified grounded theory, an iterative coding process to identify patterns of responses and derive key themes. The study team examined discrepancies in the coding process to ensure reliability and establish consensus.
Results |
When aware of opioid-prescribing guidelines, emergency physicians often defined them as policies developed by individual hospitals that sometimes reflected guidelines at the state or national level. Guidelines were primarily used by physicians to communicate decisions to limit prescriptions to patients on discharge rather than as tools for decisionmaking. Attitudes toward guidelines varied with regard to general attitudes toward opioid medications, as well as the perceived effects of guidelines on physician autonomy, public health, liability, and patient diversion.
Conclusion |
These exploratory findings suggest that hospital-based opioid guidelines complement and occasionally supersede state and national guidelines and that emergency physicians apply guidelines primarily as communication tools. The perspectives of providers should inform future policy actions that seek to address the problem of opioid abuse and overdose through practice guidelines.
Le texte complet de cet article est disponible en PDF.Plan
| Please see page 483 for the Editor's Capsule Summary of this article. |
|
| Supervising editor: Lewis S. Nelson, MD |
|
| Author contributions: ASK, JP, FKB, and ZFM conceived and designed the study. ASK and ZFM acquired the data, with supervision from FKB. All authors analyzed and interpreted the data. ASK, SMG, and ZFM drafted the article, and all authors critically revised it for important intellectual content. SMG and BP provided technical support and managed the data. ZFM obtained research funding. ZFM takes responsibility for the paper as a whole. |
|
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org/). The authors have stated that no such relationships exist and provided the following details: This project was supported in part by an Agency for Healthcare Research and Quality Patient-Centered Outcomes Research and Dissemination Award (Dr. Meisel), R18 HS021956-01. Additional support was provided by a National Institutes of Health Career Development Award in comparative effectiveness research (Dr. Meisel), KM1 CA156715-01. |
|
| A JBYGNTB survey is available with each research article published on the Web at www.annemergmed.com. |
|
| A podcast for this article is available at www.annemergmed.com. |
Vol 64 - N° 5
P. 482 - novembre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
